0.2159
price down icon4.34%   -0.0098
after-market After Hours: .22 0.0041 +1.90%
loading
Azitra Inc stock is traded at $0.2159, with a volume of 1.07M. It is down -4.34% in the last 24 hours and down -15.33% over the past month. Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.2257
Open:
$0.2247
24h Volume:
1.07M
Relative Volume:
0.40
Market Cap:
$3.72M
Revenue:
$1.27M
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.00962
EPS:
-22.4496
Net Cash Flow:
$-10.46M
1W Performance:
-4.89%
1M Performance:
-15.33%
6M Performance:
-19.41%
1Y Performance:
-81.06%
1-Day Range:
Value
$0.2126
$0.226
1-Week Range:
Value
$0.2126
$0.2399
52-Week Range:
Value
$0.2126
$1.143

Azitra Inc Stock (AZTR) Company Profile

Name
Name
Azitra Inc
Name
Phone
203 646 6446
Name
Address
21 Business Park Drive, Branford
Name
Employee
10
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
AZTR's Discussions on Twitter

Compare AZTR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
AZTR
Azitra Inc
0.2159 3.89M 1.27M -11.28M -10.46M -22.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Azitra Inc Stock (AZTR) Latest News

pulisher
Jul 25, 2025

What analysts say about Azitra Inc. stockPhenomenal wealth increase - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Azitra Inc. a good long term investmentUnprecedented market success - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Azitra Inc. stock priceSky-high profits - Autocar Professional

Jul 25, 2025
pulisher
Jul 23, 2025

Azitra Inc. Stock Analysis and ForecastHigh-yield market plays - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Why Azitra Inc. stock attracts strong analyst attentionSafer Investing With Bigger Upside - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-22 12:38:35 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

What makes Azitra Inc. stock price move sharplyCapital Preservation Investment Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Azitra Inc. stock performs during market volatilityShort Term Profit Focus - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

A Closer Look at Azitra Inc (AZTR) Stock Gains - investchronicle.com

Jul 10, 2025
pulisher
Jul 04, 2025

Azitra Inc. issues new warrants in connection with stock sale - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Azitra shareholders approve doubling of authorized common stock - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

Azitra shareholders approve doubling of authorized common stock By Investing.com - Investing.com Canada

Jul 03, 2025
pulisher
Jun 23, 2025

Azitra Inc Approves Director Elections and Share Issuance - TipRanks

Jun 23, 2025
pulisher
Jun 18, 2025

Azitra Inc Plans Stock Increase at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 17, 2025

Azitra reports safety data from Netherton syndrome treatment trial - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Azitra reports safety data from Netherton syndrome treatment trial By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

AZTR’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jun 17, 2025
pulisher
Jun 17, 2025

Azitra Inc Announces Positive Phase 1b Trial Results - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome - PR Newswire

Jun 17, 2025
pulisher
Jun 13, 2025

Azitra (NYSEAMERICAN:AZTR) Stock Price Up 2% – Still a Buy? - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Azitra Inc (AZTR) Stock: A Year of Market Fluctuations - investchronicle.com

Jun 12, 2025
pulisher
Jun 10, 2025

Azitra Reveals Latest Clinical Progress: Two Novel Dermatology Treatments Take Center Stage at BIO 2025 - Stock Titan

Jun 10, 2025
pulisher
May 28, 2025

Revolutionary Skin Microbiome Treatment Could Help Cancer Patients Stay on Life-Saving Therapy - Stock Titan

May 28, 2025
pulisher
May 28, 2025

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash - PR Newswire

May 28, 2025
pulisher
May 24, 2025

FY2025 EPS Estimates for Azitra Lifted by Zacks Small Cap - Defense World

May 24, 2025
pulisher
May 23, 2025

What is Zacks Small Cap’s Forecast for Azitra Q2 Earnings? - Defense World

May 23, 2025
pulisher
May 22, 2025

AZTR: ATR-04 Trial to Dose 1st Patient Mid-2025 - MSN

May 22, 2025

Azitra Inc Stock (AZTR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):